AIMS microbiology |
Pubbl/distr/stampa | Springfield, MO : , : AIMS Press, , [2015]- |
Descrizione fisica | 1 online resource |
Disciplina | 579 |
Soggetto topico |
Microbiology
Microbiological Phenomena |
Soggetto genere / forma |
Periodical
Periodicals. |
ISSN | 2471-1888 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | American Institute of Mathematical Sciences microbiology |
Record Nr. | UNINA-9910136811003321 |
Springfield, MO : , : AIMS Press, , [2015]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
AIMS microbiology |
Pubbl/distr/stampa | Springfield, MO : , : AIMS Press, , [2015]- |
Descrizione fisica | 1 online resource |
Disciplina | 579 |
Soggetto topico |
Microbiology
Microbiological Phenomena |
Soggetto genere / forma |
Periodical
Periodicals. |
ISSN | 2471-1888 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | American Institute of Mathematical Sciences microbiology |
Record Nr. | UNISA-996302250403316 |
Springfield, MO : , : AIMS Press, , [2015]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
Autore | Organization World Health |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 616 |
Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
Soggetto genere / forma |
Electronic books.
Publication Formats Technical Report |
ISBN | 92-4-069266-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
Record Nr. | UNINA-9910511992203321 |
Organization World Health | ||
Geneva, : World Health Organization, 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
Autore | Organization World Health |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 616 |
Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
Soggetto genere / forma |
Publication Formats
Technical Report |
ISBN | 92-4-069266-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
Record Nr. | UNINA-9910786624203321 |
Organization World Health | ||
Geneva, : World Health Organization, 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
Autore | Organization World Health |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
Descrizione fisica | 1 online resource (254 p.) |
Disciplina | 616 |
Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
Soggetto genere / forma |
Publication Formats
Technical Report |
ISBN | 92-4-069266-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
Record Nr. | UNINA-9910825162403321 |
Organization World Health | ||
Geneva, : World Health Organization, 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Applied biological chemistry |
Pubbl/distr/stampa | New York : , : Springer, , [2016]- |
Soggetto topico |
Agricultural chemistry - Korea (South)
Agricultural chemicals - Korea (South) Biochemistry Agricultural chemistry Agricultural chemicals Biochemical Phenomena Microbiological Phenomena Ecological and Environmental Phenomena Food Technology |
Soggetto genere / forma | Periodicals. |
ISSN | 2468-0842 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | ABCH |
Record Nr. | UNISA-996321502303316 |
New York : , : Springer, , [2016]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Applied biological chemistry |
Pubbl/distr/stampa | New York : , : Springer, , [2016]- |
Soggetto topico |
Agricultural chemistry - Korea (South)
Agricultural chemicals - Korea (South) Biochemistry Agricultural chemistry Agricultural chemicals Biochemical Phenomena Microbiological Phenomena Ecological and Environmental Phenomena Food Technology |
Soggetto genere / forma | Periodicals. |
ISSN | 2468-0842 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | ABCH |
Record Nr. | UNINA-9910316458403321 |
New York : , : Springer, , [2016]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Current clinical microbiology reports |
Pubbl/distr/stampa | [Cham] : , : Springer International Publishing, , [2014]- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Medical microbiology
Microbiology Microbiological Phenomena Microbiological Techniques |
Soggetto genere / forma |
Periodicals.
Periodical Review |
Soggetto non controllato | Microbiology & Immunology |
ISSN | 2196-5471 |
Classificazione |
42.30
44.43 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910307941503321 |
[Cham] : , : Springer International Publishing, , [2014]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Current clinical microbiology reports |
Pubbl/distr/stampa | [Cham] : , : Springer International Publishing, , [2014]- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Medical microbiology
Microbiology Microbiological Phenomena Microbiological Techniques |
Soggetto genere / forma |
Periodicals.
Periodical Review |
Soggetto non controllato | Microbiology & Immunology |
ISSN | 2196-5471 |
Classificazione |
42.30
44.43 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996200002003316 |
[Cham] : , : Springer International Publishing, , [2014]- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Essential Microbiology |
Autore | Hogg Stuart |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Hoboken : , : John Wiley & Sons, Incorporated, , 2013 |
Descrizione fisica | 1 online resource (527 pages) |
Disciplina | 579 |
Soggetto topico | Microbiological Phenomena |
Soggetto genere / forma | Electronic books. |
ISBN |
9781118527252
9781119978909 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Essential Microbiology -- Contents -- Preface to Second Edition -- Preface to First Edition -- Acknowledgements -- About the Companion Website -- I Introduction -- 1 Microbiology: What, Why and How? -- 1.1 What is microbiology? -- 1.2 Why is microbiology important? -- 1.3 How do we know? Microbiology in perspective: to the Golden Age and beyond -- 1.4 Light microscopy -- 1.5 Electron microscopy -- 2 Biochemical Principles -- 2.1 Atomic structure -- 2.1.1 Isotopes -- 2.1.2 Chemical bonds -- 2.2 Acids, bases and pH -- 2.3 Biomacromolecules -- 2.3.1 Carbohydrates -- 2.3.2 Proteins -- 2.3.3 Higher levels of protein structure -- 2.3.4 Nucleic acids -- 2.3.5 Lipids -- 3 Cell Structure and Organisation -- 3.1 The prokaryotic cell -- 3.1.1 Prokaryotic cell structure -- 3.1.2 Genetic material -- 3.1.3 Ribosomes -- 3.1.4 Inclusion bodies -- 3.1.5 Endospores -- 3.1.6 The plasma membrane -- 3.1.7 The bacterial cell wall -- 3.1.8 Beyond the cell wall -- 3.2 The eukaryotic cell -- 3.2.1 The nucleus -- 3.2.2 Endoplasmic reticulum -- 3.2.3 Golgi apparatus -- 3.2.4 Lysosomes -- 3.2.5 Mitochondria -- 3.2.6 Chloroplasts -- 3.2.7 Vacuoles -- 3.2.8 Plasma membrane -- 3.2.9 Cell wall -- 3.2.10 Flagella and cilia -- 3.3 Cell division in prokaryotes and eukaryotes -- II Microbial Nutrition, Growth and Metabolism -- 4 Microbial Nutrition and Cultivation -- 4.1 Nutritional categories -- 4.2 How do nutrients get into the microbial cell? -- 4.3 Laboratory cultivation of microorganisms -- 4.3.1 Obtaining a pure culture -- 4.3.2 Growth media for the cultivation of bacteria -- 4.3.3 Preservation of microbial cultures -- 5 Microbial Growth -- 5.1 Estimation of microbial numbers -- 5.2 Factors affecting microbial growth -- 5.2.1 Temperature -- 5.2.2 pH -- 5.2.3 Oxygen -- 5.2.4 Carbon dioxide -- 5.2.5 Osmotic pressure -- 5.2.6 Light.
5.3 The kinetics of microbial growth -- 5.3.1 Lag phase -- 5.3.2 Log (exponential) phase -- 5.3.3 Stationary phase -- 5.3.4 Death phase -- 5.3.5 Batch culture and continuous culture -- 5.4 Growth in multicellular microorganisms -- 6 Microbial Metabolism -- 6.1 Why is energy needed? -- 6.2 Enzymes -- 6.2.1 Enzyme classification -- 6.2.2 Certain enzymes have a non-protein component -- 6.2.3 How do enzymes speed up a reaction? -- 6.2.4 Environmental factors affect enzyme activity -- 6.3 Principles of energy generation -- 6.3.1 Oxidation-reduction reactions -- 6.3.2 Why glucose? -- 6.3.3 Glycolysis -- 6.3.4 Glycolysis is not the only way to metabolise glucose -- 6.3.5 Aerobic respiration -- 6.3.6 Oxidative phosphorylation and the electron transport chain -- 6.3.7 Fermentation -- 6.3.8 Other types of fermentation -- 6.3.9 Metabolism of lipids and proteins -- 6.3.10 Anaerobic respiration -- 6.3.11 Energy may be generated by the oxidation of inorganic molecules -- 6.4 Photosynthesis -- 6.4.1 Oxygenic photosynthesis -- 6.4.2 Where does photosynthesis take place? -- 6.4.3 'Light' reactions -- 6.4.4 'Dark' reactions -- 6.4.5 Anoxygenic photosynthesis -- 6.5 Anabolic reactions -- 6.5.1 Biosynthesis of carbohydrates -- 6.5.2 Biosynthesis of lipids -- 6.5.3 Biosynthesis of nucleic acids -- 6.5.4 Biosynthesis of amino acids -- 6.6 The regulation of metabolism -- III Microbial Diversity -- 7 Prokaryote Diversity -- 7.1 Domain: Archaea -- 7.1.1 General features of the Archaea -- 7.1.2 Classification of the Archaea -- 7.2 Domain: Bacteria -- 7.2.1 Phylum: Proteobacteria -- 7.2.2 Other Gram-negative phyla -- 7.2.3 The Gram-positive bacteria: phyla Actinobacteria, Firmicutes and Tenericutes -- 8 The Fungi -- 8.1 General biology of the fungi -- 8.1.1 Morphology -- 8.1.2 Nutrition -- 8.1.3 Reproduction -- 8.2 Classification of the Fungi -- 8.2.1 Phylum Ascomycota. 8.2.2 Phylum Basidiomycota -- 8.2.3 Phylum Microsporidia -- 8.2.4 Phylum Chytridiomycota -- 8.2.5 Phylum Blastocladiomycota and phylum Neocallimastigomycota -- 8.2.6 Phylum Glomeromycota -- 8.2.7 Subphyla incertae sedis -- 9 The Protista -- 9.1 The 'algae' -- 9.1.1 Structural characteristics of algal protists -- 9.1.2 Euglenophyta -- 9.1.3 Dinoflagellata -- 9.1.4 Diatoms -- 9.1.5 Chlorophyta -- 9.1.6 Phaeophyta -- 9.1.7 Rhodophyta -- 9.2 The 'protozoa' -- 9.2.1 The zooflagellates (Mastigophora) -- 9.2.2 The amoebas (Sarcodina) -- 9.2.3 Amoebas with external shells: Foraminifera and Radiolaria -- 9.2.4 The ciliates (Ciliophora) -- 9.2.5 The Sporozoans (Apicomplexa) -- 9.3 The slime moulds and water moulds (the fungus-like protists) -- 9.3.1 Oomycota (water moulds) -- 9.3.2 Myxogastrida (Myxomycota, the plasmodial slime moulds) -- 9.3.3 Dictyostelida (cellular slime moulds) -- 9.4 Protistan taxonomy: a modern view -- 10 Viruses -- 10.1 What are viruses? -- 10.2 Viral structure -- 10.2.1 The viral genome -- 10.2.2 Capsid structure -- 10.2.3 The viral envelope -- 10.3 Classification of viruses -- 10.4 Viral replication cycles -- 10.4.1 Replication cycles in bacteriophages -- 10.4.2 Lysogenic replication cycle -- 10.4.3 Replication cycles in animal viruses -- 10.4.4 Replication of RNA viruses -- 10.4.5 Replication cycles in plant viruses -- 10.5 Viroids -- 10.6 Prions -- 10.7 Cultivating viruses -- IV Microbial Genetics -- 11 Microbial Genetics -- 11.1 How do we know genes are made of DNA? -- 11.2 DNA replication -- 11.2.1 DNA replication in prokaryotes -- 11.2.2 What happens when replication goes wrong? -- 11.2.3 DNA replication in eukaryotes -- 11.3 What exactly do genes do? -- 11.3.1 How does a gene direct the synthesis of a protein? -- 11.3.2 The genetic code -- 11.3.3 Transcription in prokaryotes -- 11.3.4 Translation. 11.4 Regulation of gene expression -- 11.4.1 Induction of gene expression -- 11.4.2 Repression of gene expression -- 11.4.3 Global gene regulation -- 11.5 The molecular basis of mutations -- 11.5.1 How do mutations occur? -- 11.5.2 Mutations can add or remove nucleotides -- 11.5.3 Mutations can be reversed -- 11.5.4 Mutations have a variety of mechanisms -- 11.5.5 Mutations also occur in viruses -- 11.5.6 Mutagenic agents increase the rate of mutations -- 11.5.7 DNA damage can be repaired -- 11.5.8 Carcinogenicity testing: the Ames test -- 11.6 Genetic transfer in microorganisms -- 11.6.1 Transformation -- 11.6.2 How does transformation occur? -- 11.6.3 Induced competence -- 11.6.4 Conjugation -- 11.6.5 Gene transfer in conjugation is one way only -- 11.6.6 Transduction -- 11.6.7 Transposable elements -- 12 Microorganisms in Genetic Engineering -- 12.1 Plasmid cloning vectors -- 12.2 Bacteriophages as cloning vectors -- 12.3 YACs, BACs and PACs -- 12.4 Expression vectors -- 12.5 Eukaryotic cloning vectors -- 12.6 Viruses as vectors in eukaryotic systems -- 12.7 Cloning vectors for higher plants -- 12.8 Applications of gene cloning in the microbial world -- 12.9 DNA microarrays -- 12.10 Polymerase chain reaction (PCR) -- V Microorganisms in the Environment -- 13 Microbial Associations -- 13.1 Microbial associations with animals -- 13.2 Microbial associations with plants -- 13.2.1 Plant diseases -- 13.3 Microbial associations with other microorganisms -- 14 Microorganisms in the Environment -- 14.1 The carbon cycle -- 14.2 The nitrogen cycle -- 14.3 The sulphur cycle -- 14.4 The microbiology of soil -- 14.5 The microbiology of freshwater -- 14.6 The microbiology of seawater -- 14.7 Detection and isolation of microorganisms in the environment -- 14.8 Beneficial effects of microorganisms in the environment. 14.8.1 Solid waste treatment: composting and landfill -- 14.8.2 Wastewater treatment -- 14.8.3 Bioremediation -- 14.9 Harmful effects of microorganisms in the environment -- VI Medical Microbiology -- 15 Human Microbial Diseases -- 15.1 Transmission -- 15.2 Attachment and colonisation -- 15.2.1 Skin -- 15.2.2 Mucous membranes -- 15.2.3 How do pathogens penetrate the mucosa? -- 15.3 Bacterial toxins -- 15.3.1 Exotoxins -- 15.3.2 Endotoxins -- 15.3.3 Superantigens -- 15.3.4 Siderophores -- 15.4 Bacterial diseases in humans -- 15.4.1 Waterborne transmission: cholera -- 15.4.2 Airborne transmission: 'strep' throat -- 15.4.3 Contact transmission: syphilis -- 15.4.4 Vector-borne transmission: plague -- 15.5 Viral diseases in humans -- 15.5.1 Airborne transmission: influenza -- 15.5.2 Transmission by water or food: viral gastroenteritis -- 15.5.3 Vector-borne transmission -- 15.5.4 Latent and slow (persistent) viral infections -- 15.5.5 Viruses and cancer -- 15.5.6 Emerging and re-emerging viral diseases -- 15.5.7 Virus vaccines -- 15.6 Protists and disease -- 15.6.1 Malaria -- 15.6.2 Toxoplasmosis -- 15.6.3 Cryptosporidiosis -- 15.6.4 Leishmaniasis -- 15.6.5 Amoebic dysentery -- 15.7 Fungal diseases in humans -- 15.8 Algal diseases of humans -- 16 The Control of Microorganisms -- 16.1 Sterilisation -- 16.1.1 Sterilisation by irradiation -- 16.1.2 Filtration -- 16.1.3 Sterilisation using ethylene oxide -- 16.2 Disinfection -- 16.2.1 Alcohols -- 16.2.2 Halogens -- 16.2.3 Phenolics -- 16.2.4 Surfactants -- 16.3 The kinetics of cell death -- 16.3.1 Killing by irradiation -- 17 Antimicrobial Agents -- 17.1 Antibiotics -- 17.1.1 What other properties should an antibiotic have? -- 17.1.2 How do antibiotics work? -- 17.1.3 I: Inhibitors of cell wall synthesis -- 17.1.4 II: Antibiotics that disrupt cell membranes -- 17.1.5 III: Inhibitors of protein synthesis. 17.1.6 IV: Inhibitors of nucleic acid synthesis. |
Record Nr. | UNINA-9910795833603321 |
Hogg Stuart | ||
Hoboken : , : John Wiley & Sons, Incorporated, , 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|